SCHEMBL6172495

SCHEMBL6172495

CC(=O)NC(c1ccncc1N1CCN(C)CC1)N1CC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 1/20 0.36
GPR139 Q6DWJ6 1/20 0.36
KCNH2 Q12809 2/20 0.35
ABL1 P00519 1/20 0.35
TRPV4 Q9HBA0 4/20 0.34
SCN5A Q14524 1/20 0.34
SCN9A Q15858 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
ATM Q13315 1/20 0.34
MAPK7 Q13164 1/20 0.34
EPHX2 P34913 1/20 0.33
CYP3A4 P08684 1/20 0.33
MAP4K1 Q92918 1/20 0.33
CYP2C9 P11712 2/20 0.32
P2RX3 P56373 2/20 0.32
ACACB O00763 2/20 0.32
KCNA5 P22460 1/20 0.32
MCHR1 Q99705 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6171968 0.78 CYP3A4 (0.36) HTR2CGPR139KCNH2ABL1TRPV4
SCHEMBL2938270 0.76 ACACB (0.37) GPR139ABL1ACACB
SCHEMBL2940231 0.76 KMT2A (0.48) GPR139TRPV4MEN1KMT2AATM
SCHEMBL2941164 0.75 ALDH1A1 (0.39) HTR2CKCNH2ABL1TRPV4MEN1
SCHEMBL6173460 0.74 HTR2A (0.34) MAPK7
SCHEMBL6173623 0.72 IGF1R (0.38) MEN1KMT2ACYP3A4CYP2C9
SCHEMBL6177656 0.72 LMNA (0.37) HTR2CGPR139KCNH2ABL1TRPV4
SCHEMBL6174909 0.72 TRPV4 (0.37) HTR2CGPR139KCNH2ABL1TRPV4
SCHEMBL6173204 0.69 CACNA1B (0.37) HTR2CABL1CYP3A4CYP2C9
SCHEMBL2932740 0.68 CACNA1G (0.41) KMT2AEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed